483 AstraZeneca Pharmaceuticals, LP Jun 2004

483 AstraZeneca Pharmaceuticals, LP Jun 2004

Tammy Chavis FDA, Michael Omeara FDA$119.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals, LP - Newark, DE, United States facility and issued inspectional observations (via FDA 483) on 24 Jun 2004.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Jun 2004
  • Location: Newark, United States
  • FEI: 2517100
Add To Cart